StockDriftsStockDriftsSamsung Pharmaceutical (001360) has 0 disclosed insider purchases and 2 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩13M ($9K) in reported transaction value. The earliest filing StockDrifts holds for Samsung Pharmaceutical is dated 2024-02-23; the most recent is 2024-06-12. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -28.76%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | SELL | Market Sell | 전상일 Jeon Sang-il | moving | -5.0K | ₩1,604 | -30.3% | ₩8M ($6K) |
| 2024-05-28 | SELL | Market Sell | 전상일 Jeon Sang-il | moving | -3.0K | ₩1,643 | -27.2% | ₩5M ($3K) |
| 2024-04-30 | BUY | 신규보고 | 최영선 Choi Young-seon | Managing Director | 1.0K | ₩1,718 | +21.6% | ₩2M ($1K) |
| 2024-04-30 | BUY | 신규보고 | 전상일 Jeon Sang-il | moving | 12.2K | ₩1,718 | +21.6% | ₩21M ($15K) |
| 2024-02-23 | BUY | 유상신주취득 | 정경표 Jeong Kyung-pyo | moving | 1.4K | ₩2,200 | -5.0% | ₩3M ($2K) |
| 2024-02-23 | BUY | 유상신주취득 | 박봉권 Park Bong-kwon | Outside Director | 568 | ₩2,200 | -5.0% | ₩1M ($868) |
| 2024-02-23 | BUY | 유상신주취득 | 젬백스 Gemvax | - | 2.8M | ₩2,200 | -5.0% | ₩6.2B ($4.3M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Samsung Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.